↓ Skip to main content

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

Overview of attention for article published in Psychopharmacology, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy
1 policy source
patent
1 patent
wikipedia
2 Wikipedia pages
video
1 YouTube creator

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
Published in
Psychopharmacology, March 2013
DOI 10.1007/s00213-013-3067-z
Pubmed ID
Authors

Mohammad Haghighi, Leila Jahangard, Hamid Mohammad-Beigi, Hafez Bajoghli, Hassan Hafezian, Alireza Rahimi, Hamid Afshar, Edith Holsboer-Trachsler, Serge Brand

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Unknown 93 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 16 17%
Student > Master 13 14%
Researcher 9 9%
Student > Ph. D. Student 9 9%
Student > Postgraduate 8 8%
Other 14 15%
Unknown 26 27%
Readers by discipline Count As %
Medicine and Dentistry 29 31%
Psychology 14 15%
Neuroscience 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Agricultural and Biological Sciences 3 3%
Other 6 6%
Unknown 29 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2019.
All research outputs
#3,196,067
of 22,805,349 outputs
Outputs from Psychopharmacology
#812
of 5,347 outputs
Outputs of similar age
#27,713
of 197,701 outputs
Outputs of similar age from Psychopharmacology
#11
of 63 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,347 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,701 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.